Accesso libero

Cefiderocol and Intraventricular Colistin for Ventriculitis due to an Extensively Drug-Resistant Pseudomonas Aeruginosa

INFORMAZIONI SU QUESTO ARTICOLO

Cita

Fig. 1.

Brain MRI. Axial diffusion weighted image (A), ADC map (B), T1 SE post-contrast (C), and T2*-GRE (D), demonstrating signs of ventriculitis manifested by an increase in dimensions and ‘tension’ of the walls in the occipital and temporal horns of the ventricular system [C, blue arrows]. Content with restricted diffusion and a liquid level in the occipital horns: indicating purulent content [A–B: red arrow]. There is no significant blooming in T2* suggestive of hemorrhage [D].
Brain MRI. Axial diffusion weighted image (A), ADC map (B), T1 SE post-contrast (C), and T2*-GRE (D), demonstrating signs of ventriculitis manifested by an increase in dimensions and ‘tension’ of the walls in the occipital and temporal horns of the ventricular system [C, blue arrows]. Content with restricted diffusion and a liquid level in the occipital horns: indicating purulent content [A–B: red arrow]. There is no significant blooming in T2* suggestive of hemorrhage [D].

Fig. 2.

Brain MRI. Axial diffusion weighted image (A), ADC map (B), T2/FLAIR (fluid-attenuation-inversion-recovery) (C) and T1 SE post contrast (D), showing increased signal in T2iFLAIR image at the adjacent bilateral periventricular parenchyma [C, blue arrows], with restricted diffusion [A-B] and anomalous contrast enhancement [D], exhibiting signs of loculation in the right parietal white matter [D, yellow arrow] and some focal contralateral nodules [I), red arrows].
Brain MRI. Axial diffusion weighted image (A), ADC map (B), T2/FLAIR (fluid-attenuation-inversion-recovery) (C) and T1 SE post contrast (D), showing increased signal in T2iFLAIR image at the adjacent bilateral periventricular parenchyma [C, blue arrows], with restricted diffusion [A-B] and anomalous contrast enhancement [D], exhibiting signs of loculation in the right parietal white matter [D, yellow arrow] and some focal contralateral nodules [I), red arrows].

Fig. 3.

Timeline of events, microbiological findings, and antimicrobial periods. Abbreviations: BRS- bronchial respiratory sample: CSF- cerebral spinal fluid d- days: I, intravenous: IVT- intraventricular: Nal- Magnetic resonance imaging: XDR- Extensively drug-resistant.
Timeline of events, microbiological findings, and antimicrobial periods. Abbreviations: BRS- bronchial respiratory sample: CSF- cerebral spinal fluid d- days: I, intravenous: IVT- intraventricular: Nal- Magnetic resonance imaging: XDR- Extensively drug-resistant.

Evolution of Pseudomonas Aeruginosa susceptibility testing.

Antibiogram CSF (day 25) BRS (day 25) BRS (day 48)
Piperacillin-tazobactam R R R
Amikacin - - -
Aztreonam R R R
Cefepime R R SIE
Ceftazidime R R R
Ciprofloxacin R R R
Imipenem R R R
Meropenem R R R (>32 mg/l)
Tobramycin S S S
Levofloxacin R R R
Colistin S S (1.0 mg/l) S (2.0 mg/l)
Ceftazidime-avibactam R R R (>256 mg/l)
Ceftolozane-tazobactam S S R
Imipenem-cilastin-relebactam R (6.0 mg/l) R R (4.0 mg/l)
Meropenem-varobactam - - -
eISSN:
2393-1817
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicine, Clinical Medicine, Internal Medicine, other, Surgery, Anaesthesiology, Emergency Medicine and Intensive-Care Medicine